CSPC Innovation Pharmaceutical Co Ltd Class A - Asset Resilience Ratio
CSPC Innovation Pharmaceutical Co Ltd Class A (300765) has an Asset Resilience Ratio of 5.64% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See CSPC Innovation Pharmaceutical Co Ltd Cl (300765) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2025)
This chart shows how CSPC Innovation Pharmaceutical Co Ltd Class A's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is CSPC Innovation Pharmaceutical Co Ltd Cl's balance sheet.
Liquid Assets Composition Over Time
This chart breaks down CSPC Innovation Pharmaceutical Co Ltd Class A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read 300765 current and long-term liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥350.30 Million | 5.64% |
| Total Liquid Assets | CN¥350.30 Million | 5.64% |
Asset Resilience Insights
- Limited Liquidity: CSPC Innovation Pharmaceutical Co Ltd Class A maintains only 5.64% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
CSPC Innovation Pharmaceutical Co Ltd Class A Industry Peers by Asset Resilience Ratio
Compare CSPC Innovation Pharmaceutical Co Ltd Class A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
B&G Foods Inc
NYSE:BGS |
Packaged Foods | 1.99% |
|
Saputo Inc
TO:SAP |
Packaged Foods | 3.36% |
|
Lotus Bakeries
BR:LOTB |
Packaged Foods | 2.28% |
|
COFCO Tunhe Sugar Co Ltd
SHG:600737 |
Packaged Foods | 0.08% |
|
Nongshim
KO:004370 |
Packaged Foods | 25.51% |
|
Grupo Bimbo S.A.B. de C.V
MX:BIMBOA |
Packaged Foods | 0.15% |
|
Avanti Feeds Limited
NSE:AVANTIFEED |
Packaged Foods | 65.24% |
|
Juewei Food Co Ltd
SHG:603517 |
Packaged Foods | 3.18% |
Annual Asset Resilience Ratio for CSPC Innovation Pharmaceutical Co Ltd Class A (2019–2025)
The table below shows the annual Asset Resilience Ratio data for CSPC Innovation Pharmaceutical Co Ltd Class A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 6.14% | CN¥385.39 Million ≈ $56.39 Million |
CN¥6.28 Billion ≈ $918.42 Million |
-1.67pp |
| 2024-12-31 | 7.81% | CN¥470.09 Million ≈ $68.79 Million |
CN¥6.02 Billion ≈ $881.22 Million |
-3.25pp |
| 2021-12-31 | 11.06% | CN¥413.59 Million ≈ $60.52 Million |
CN¥3.74 Billion ≈ $547.46 Million |
+0.17pp |
| 2020-12-31 | 10.89% | CN¥321.94 Million ≈ $47.11 Million |
CN¥2.96 Billion ≈ $432.64 Million |
-22.77pp |
| 2019-12-31 | 33.66% | CN¥960.09 Million ≈ $140.49 Million |
CN¥2.85 Billion ≈ $417.39 Million |
-- |
About CSPC Innovation Pharmaceutical Co Ltd Class A
CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. The company offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, and doxofylline; and health food product… Read more